The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients.

Abstract

The use of primary tacrolimus therapy was associated with a significant 5-fold higher rate of PTLD when compared to those treated with primary cyclosporine. Early diagnosis, decrease and/or discontinuation of potent immunosuppressive agents may contribute to decrease morbidity and mortality of this entity.